IGM Biosciences Inc (IGMS)
9.18
-0.11
(-1.18%)
USD |
NASDAQ |
May 17, 16:00
9.18
0.00 (0.00%)
After-Hours: 20:00
IGM Biosciences Cash from Financing (Quarterly): 0.152M for March 31, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 0.152M |
| December 31, 2023 | 0.402M |
| September 30, 2023 | 44.64M |
| June 30, 2023 | 69.95M |
| March 31, 2023 | 0.075M |
| December 31, 2022 | 0.482M |
| September 30, 2022 | 0.297M |
| June 30, 2022 | 218.53M |
| March 31, 2022 | 0.072M |
| December 31, 2021 | 1.491M |
| September 30, 2021 | 1.071M |
| Date | Value |
|---|---|
| June 30, 2021 | -0.033M |
| March 31, 2021 | -0.053M |
| December 31, 2020 | 215.91M |
| September 30, 2020 | -0.917M |
| June 30, 2020 | -0.234M |
| March 31, 2020 | 0.022M |
| December 31, 2019 | -1.994M |
| September 30, 2019 | 224.65M |
| June 30, 2019 | 49.57M |
| March 31, 2019 | 10.03M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-1.994M
Minimum
Dec 2019
224.65M
Maximum
Sep 2019
41.20M
Average
0.3495M
Median
Cash from Financing (Quarterly) Benchmarks
| Akoya Biosciences Inc | -0.444M |
| Xilio Therapeutics Inc | 0.954M |
| NovaBay Pharmaceuticals Inc | -0.597M |
| Palatin Technologies Inc | 9.136M |
| iBio Inc | 4.005M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -42.42M |
| Cash from Investing (Quarterly) | 8.651M |
| Free Cash Flow | -194.58M |
| Free Cash Flow Per Share (Quarterly) | -0.7469 |
| Free Cash Flow to Equity (Quarterly) | -44.90M |
| Free Cash Flow to Firm (Quarterly) | -44.90M |
| Free Cash Flow Yield | -37.56% |